GXMC
LXRX icon

Global X Management Company’s Lexicon Pharmaceuticals LXRX Stock Holding History

Global X Management Company’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$54K Buy
4,524
+2,452
+118% +$25.1K ﹤0.01% 1071
2018
Q1 		$18K Buy
2,072
+521
+34% +$4.82K ﹤0.01% 1118
2017
Q4 		$15K Buy
1,551
+352
+29% +$3.66K ﹤0.01% 1037
2017
Q3 		$15K Buy
1,199
+173
+17% +$2.56K ﹤0.01% 1085
2017
Q2 		$17K Buy
1,026
+686
+202% +$10.6K ﹤0.01% 1178
2017
Q1 		$5K Buy
340
+20
+6% +$297 ﹤0.01% 1180
2016
Q4 		$4K Hold
320
– – ﹤0.01% 1073
2016
Q3 		$6K Hold
320
– – ﹤0.01% 1049
2016
Q2 		$5K Buy
+320
New +$4.34K ﹤0.01% 931

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SGA
Sector Gamma AS Oslo, Norway $423M AUM 17.56% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return